LFNClass II
Nephelometric Inhibition Immunoassay, Phenobarbital
21 CFR 862.3660 / Clinical Toxicology
LFN is the FDA product code for Nephelometric Inhibition Immunoassay, Phenobarbital, a class II device type, regulated under 21 CFR 862.3660. As of , FDA records hold 5 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- LFN
- Device name
- Nephelometric Inhibition Immunoassay, Phenobarbital
- Regulation
- 21 CFR 862.3660
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 5
- Ingested recalls
- 0
Clearances, product code LFN
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1982 | 1 |
| 1986 | 2 |
| 1987 | 1 |
| 1994 | 1 |
Applicants with the most clearances
Product code LFN| Applicant | Clearances |
|---|---|
| E.I. Dupont de Nemours & Co., Inc. | 2 |
| Coulter Electronics, Inc. | 1 |
| Electro-Nucleonics Laboratories, Inc. | 1 |
| Seradyn, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
